通过经手术后的血栓形成的扩散膜出血的复发,在米特拉生物修饰替换后
Ryo Nakada1, Daisuke Ueshima1, Maki Ono1
1Cardiology, Kameda General Hospital, Kamogawa-shi, JPN.
Cureus
|June 18, 2025
概括
患有全身性红斑狼和抗脂抗体综合征的患者的扩散膜出血 (DAH) 由于血栓式生物假体而复发. 强化抗血栓治疗成功管理了DAH和门功能障碍.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
背景情况:
- 一名39岁的女性患有全身性红斑狼 (SLE) 和抗脂抗体综合征 (APS) 经历了复发性扩散膜出血 (DAH).
- 该患者患有严重的额头狭窄和反,需要用生物假肢替换额头.
研究的目的:
- 在患有SLE和APS的患者中,研究生物假体中门置换后DAH复发的情况.
- 探索导致DAH的因素,包括免疫介导的毛细血管炎和心脏功能障碍.
主要方法:
- 病例报告详细介绍患者的临床过程,治疗干预措施和结果.
- 检查病史,包括住院情况,SLE和APS的诊断,以及手术程序.
- 与生物假体门功能和抗血栓治疗相关的DAH复发的分析.
主要成果:
- 在米特拉置换后六个月,DAH复发,原因是血栓形成,使米特拉狭窄症恶化.
- 强化抗血栓治疗改善了额头肌狭窄,并防止了进一步的DAH复发.
- 与SLE/APS相关的免疫媒介毛细血管炎和由米特拉病引起的肺/左心房压的增加都与DAH的发病有关.
结论:
- 生物假体栓凝血可以在患有SLE/APS的患者中导致DAH.
- 有效管理关膜疾病和适当的抗血栓治疗对于预防DAH复发至关重要.
- 对于接受生物假体门置换的APS患者,长期严格的抗血栓治疗是必不可少的.
相关概念视频
Mitral Stenosis III: Medical Management
29
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
29
Mitral Regurgitation I: Introduction
66
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
66
Mitral Valve Prolapse I: Introduction
51
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
51
Mitral Stenosis I: Introduction
51
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
51
Mitral Regurgitation III: Medical Management
35
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
35
Mitral Valve Prolapse II: Assessment and Management
48
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
48


